HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Psychiatry
FDA Approval
Prochlorperazine Labeling: Indicated for Severe Nausea/Vomiting and Schizophrenia
The FDA approved a new injection to treat severe nausea and schizophrenia when pills cannot be taken.
FDA labeling for prochlorperazine lists two approved indications: control of severe nausea and vomiting and treatment of schizophrenia. The …
A new FDA-approved injection now treats severe nausea and schizophrenia when patients cannot take pills by mouth.
FDA
Apr 15, 2026
Anesthesiology & Pain Medicine
RCT
Oliceridine PCA non-inferior to sufentanil for knee arthroplasty pain, with lower nausea and vomiting
Oliceridine shows similar pain relief to sufentanil after knee surgery with fewer side effects
A randomized controlled trial in 138 elderly patients undergoing knee arthroplasty found Oliceridine patient-controlled analgesia was non-in…
Oliceridine works as well as sufentanil for knee surgery pain but causes less nausea and vomiting in elderly patients.
Apr 6, 2026